The next portfolio you have to evaluate probably isn't yours. An acquisition lands on your desk and someone upstairs wants a view of the target's patents by Friday. Or a launch is coming and the team wants comfort that the field is clear before it ships. Either way the patents you need to understand belong to someone else, and the tools you use every day only know your own.

The usual answer is an engagement letter. Outside counsel or a search consultant takes the assignment, and weeks later a thorough report arrives, static and priced accordingly. When the whole company is riding on the answer, that's the right instrument. For the much larger number of questions that just need a defensible first read, it's slow and heavy, so the first read often doesn't happen at all. Deals get priced on a portfolio nobody actually looked inside.

ArcPrime projects now run on patents you don't own. Give it an assignee and it pulls the public portfolio. ArcPrime applies the same claim level scoring you already use on your own assets. The analysis you trust for your own pruning and filing decisions is the analysis you get on an acquisition target's IP, or on the field around a launch before it ships.

Right now your own portfolio gets claim level attention because the tooling makes it cheap, while everyone else's gets a shrug or an invoice. When the same instrument points both directions, the first read becomes cheap enough to always happen. The decisions that used to run on partial information now get actionable insights in hours. Where the stakes justify the full outside engagement, you commission it with a head start. You already know which assets matter, so the expensive hours go to the right claims.

Nothing about your existing workflow changes. External portfolios live in projects like everything else and get scored the way everything else is scored.

Book a demo and name a company you want scored. Watching ArcPrime work through a portfolio you don't own, live, is the quickest way to judge whether the read holds up.